Regulatory role of long non‑coding RNA UCA1 in signaling pathways and its clinical applications (Review)
- Authors:
- Zhaoping Liu
- Yanyan Wang
- Shunling Yuan
- Feng Wen
- Jing Liu
- Liheng Zou
- Ji Zhang
-
Affiliations: Department of Rheumatology, The First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, P.R. China, Department of Hematology, The First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, P.R. China, Molecular Biology Research Center and Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan 410078, P.R. China - Published online on: March 19, 2021 https://doi.org/10.3892/ol.2021.12665
- Article Number: 404
-
Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Abstract
 |
 |
 |
|
Kopp F and Mendell JT: Functional classification and experimental dissection of long noncoding RNAs. Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Cao H, Wahlestedt C and Kapranov P: Strategies to annotate and characterize long noncoding RNAs: Advantages and pitfalls. Trends Genet. 34:704–721. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kaikkonen MU and Adelman K: Emerging roles of non-coding RNA transcription. Trends Biochem Sci. 43:654–667. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Qian X, Zhao J, Yeung PY, Zhang QC and Kwok CK: Revealing lncRNA structures and interactions by sequencing-based approaches. Trends Biochem Sci. 44:33–52. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao G, Yao J, Kong D, Ye C, Chen R, Li L, Zeng T, Wang L, Zhang W, Shi X, et al: The Long Noncoding RNA TTTY15, Which is located on the Y chromosome, promotes prostate cancer progression by sponging let-7. Eur Urol. 76:315–326. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al: Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 12:4851–4858. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Cao Y, Xiong JB, Zhang GY, Liu Y, Jie ZG and Li ZR: Long noncoding RNA UCA1 regulates PRL-3 expression by sponging MicroRNA-495 to promote the progression of gastric cancer. Mol Ther Nucleic Acids. 19:853–864. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CJ, Zhu CC, Xu J, Wang M, Zhao WY, Liu Q, Zhao G and Zhang ZZ: The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 18:1152019. View Article : Google Scholar : PubMed/NCBI | |
|
Li O, Yi W, Yang P, Guo C and Peng C: Long non-coding RNA UCA1 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells through targeting microRNA-122. Exp Ther Med. 18:25–32. 2019.PubMed/NCBI | |
|
Wang W, Hu W, Wang Y, An Y, Song L, Shang P and Yue Z: Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA. Mol Cancer. 19:182020. View Article : Google Scholar : PubMed/NCBI | |
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. Febs J. 281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pei S, Chen J, Lu J, Hu S, Jiang L, Lei L, Ouyang Y, Fu C, Ding Y, Li S, et al: The long noncoding RNA UCA1 negatively regulates melanogenesis in melanocytes. J Invest Dermatol. 140:152–163.e5. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Neve B, Jonckheere N, Vincent A and Van Seuningen I: Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer. Cancers (Basel). 10:4402018. View Article : Google Scholar | |
|
Liao K, Xu J, Yang W, You X, Zhong Q and Wang X: The research progress of LncRNA involved in the regulation of inflammatory diseases. Mol Immunol. 101:182–188. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liang X, Qi M, Wu R, Liu A, Chen D, Tang L, Chen J, Hu X, Li W, Zhan L, et al: Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways. Int J Oncol. 53:2671–2682. 2018.PubMed/NCBI | |
|
Yu Y, Li M, Song Y, Xu J and Qi F: Overexpression of long noncoding RNA CUDR promotes hepatic differentiation of human umbilical cord mesenchymal stem cells. Mol Med Rep. 21:1051–1058. 2020.PubMed/NCBI | |
|
Jiang CR and Li TH: Circulating UCA1 is highly expressed in patients with systemic lupus erythematosus and promotes the progression through the AKT pathway. Eur Rev Med Pharmacol Sci. 22:2364–2371. 2018.PubMed/NCBI | |
|
Shi CH, Huang Y, Li WQ and Chen RG: Influence of LncRNA UCA1 on glucose metabolism in rats with diabetic nephropathy through PI3K-Akt signaling pathway. Eur Rev Med Pharmacol Sci. 23:10058–10064. 2019.PubMed/NCBI | |
|
Cai L, Tu L, Li T, Yang X, Ren Y, Gu R, Zhang Q, Yao H, Qu X, Wang Q and Tian J: Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway. Int Immunopharmacol. 75:1057342019. View Article : Google Scholar : PubMed/NCBI | |
|
Wu J, Li W, Ning J, Yu W, Rao T and Cheng F: Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition. Onco Targets Ther. 12:495–508. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 6:238922016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao B, Lu Y, Cao X, Zhu W, Kong L, Ji H, Zhang F, Lin X, Guan Q, Ou K, et al: MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1. Onco Targets Ther. 12:4509–4516. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Luan Y, Li X, Luan Y, Zhao R, Li Y, Liu L, Hao Y, Oleg Vladimir B and Jia L: Circulating lncRNA UCA1 promotes malignancy of colorectal cancer via the miR-143/MYO6 Axis. Mol Ther Nucleic Acids. 19:790–803. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li F and Hu CP: Long Non-Coding RNA urothelial carcinoma associated 1 (UCA1): Insight into its role in human diseases. Crit Rev Eukaryot Gene Expr. 25:191–197. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li N, Cui M, Yu P and Li Q: Correlations of lncRNAs with cervical lymph node metastasis and prognosis of papillary thyroid carcinoma. Onco Targets Ther. 12:1269–1278. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Feng W, Gu S, Wang H, Zhang Y, Chen W, Xu W, Lin C, Gong A and Xu M: The UCA1/KRAS axis promotes human pancreatic ductal adenocarcinoma stem cell properties and tumor growth. Am J Cancer Res. 9:496–510. 2019.PubMed/NCBI | |
|
Chen L, Cao P, Wu Q, Guo Y, Yang Y and Chen F: Overexpression of LncRNA-UCA1 correlates with lung adenocarcinoma progression and poor Prognosis. Clin Lab. 65:2019. View Article : Google Scholar | |
|
Lee JJ, Kim M and Kim HP: Epigenetic regulation of long noncoding RNA UCA1 by SATB1 in breast cancer. BMB Rep. 49:578–583. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Guo X, Zhang Y, Mayakonda A, Madan V, Ding LW, Lin LH, Zia S, Gery S, Tyner JW, Zhou W, et al: ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer. Oncogene. 37:5939–5951. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Sadek KM, Lebda MA, Nasr NE, Nasr SM and El-Sayed Y: Role of lncRNAs as prognostic markers of hepatic cancer and potential therapeutic targeting by S-adenosylmethionine via inhibiting PI3K/Akt signaling pathways. Environ Sci Pollut Res Int. 25:20057–20070. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xue M, Li X, Wu W, Zhang S, Wu S, Li Z and Chen W: Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein alpha contributes to bladder cancer cell growth and reduced apoptosis. Oncol Rep. 31:1993–2000. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li GY, Wang W, Sun JY, Xin B, Zhang X, Wang T, Zhang QF, Yao LB, Han H, Fan DM, et al: Long non-coding RNAs AC026904.1 and UCA1: A ‘one-two punch’ for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer. Theranostics. 8:2846–2861. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jin B, Gong Y, Li H, Jiao L, Xin D, Gong Y, He Z, Zhou L, Jin Y, Wang X, et al: C/EBPβ promotes the viability of human bladder cancer cell by contributing to the transcription of bladder cancer specific lncRNA UCA1. Biochem Biophys Res Commun. 506:674–679. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu W, Zhang S, Li X, Xue M, Cao S and Chen W: Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One. 8:e739202013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang ZQ, Cai Q, Hu L, He CY, Li JF, Quan ZW, Liu BY, Li C and Zhu ZG: Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer. Cell Death Dis. 8:e28392017. View Article : Google Scholar : PubMed/NCBI | |
|
Cui X, Zhao C, Yao X, Qian B, Su C, Ren Y, Yao Z, Gao X and Yang J: SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma. RNA Biol. 15:1364–1375. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Su Y, Zhou Y, Sun YJ, Wang YL, Yin JY, Huang YJ, Zhang JJ, He AN, Han K, Zhang HZ, et al: Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1. J Mol Med (Berl). 97:49–61. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bourguignon LYW: Matrix hyaluronan-CD44 interaction activates MicroRNA and LncRNA Signaling Associated With chemoresistance, invasion, and tumor progression. Front Oncol. 9:4922019. View Article : Google Scholar : PubMed/NCBI | |
|
Hung YP, Redig A, Hornick JL and Sholl LM: ARID1A mutations and expression loss in non-small cell lung carcinomas: Clinicopathologic and molecular analysis. Mod Pathol. 33:2256–2268. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang T, Gao X, Zhou K, Jiang T, Gao S, Liu P, Zuo X and Shi X: Role of ARID1A in epithelial-mesenchymal transition in breast cancer and its effect on cell sensitivity to 5-FU. Int J Mol Med. 46:1683–1694. 2020.PubMed/NCBI | |
|
Ferri-Borgogno S, Barui S, McGee AM, Griffiths T, Singh PK, Piett CG, Ghosh B, Bhattacharyya S, Singhi A, Pradhan K, et al: Paradoxical Role of AT-rich interactive domain 1a in restraining pancreatic carcinogenesis. Cancers (Basel). 12:26952020. View Article : Google Scholar | |
|
Kumar PP, Emechebe U, Smith R, Franklin S, Moore B, Yandell M, Lessnick SL and Moon AM: Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. Elife. 3:e028052014. View Article : Google Scholar | |
|
Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M and Mo YY: Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis. 5:e10082014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Meng X, Chen S, Li W, Li D, Singer R and Gu W: IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p. Breast Cancer Res. 20:322018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang TH, Liang LZ, Liu XL, Wu JN, Su K, Chen JY and Zheng QY: LncRNA UCA1/miR-124 axis modulates TGFβ1-induced epithelial-mesenchymal transition and invasion of tongue cancer cells through JAG1/Notch signaling. J Cell Biochem. 120:10495–10504. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hiemer SE, Szymaniak AD and Varelas X: The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells. J Biol Chem. 289:13461–13474. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Guo J, Li Y, Duan H and Yuan L: Metformin suppresses the proliferation and promotes the apoptosis of colon cancer cells through inhibiting the expression of long noncoding RNA-UCA1. Onco Targets Ther. 13:4169–4181. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li T, Sun X and Jiang X: UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis. Tumour Biol. 39:10104283177108232017. View Article : Google Scholar : PubMed/NCBI | |
|
Guo M, Zhou JJ and Huang W: Metformin alleviates endometrial hyperplasia through the UCA1/miR144/TGFbeta1/AKT signaling pathway. Int J Mol Med. 45:623–633. 2020.PubMed/NCBI | |
|
Ding Y, Yuan X, Gu W and Lu L: Treatment with metformin prevents pre-eclampsia by suppressing migration of trophoblast cells via modulating the signaling pathway of UCA1/miR-204/MMP-9. Biochem Biophys Res Commun. 520:115–121. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zha Z, Han Q, Liu W and Huo S: lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion. J Orthop Surg Res. 15:382020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Li Y, Wang N, Li X, Zheng J and Ge L: UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1. Sci Rep. 9:66522019. View Article : Google Scholar : PubMed/NCBI | |
|
Pan J, Dai Q, Zhang T and Li C: Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway. Cancer Cell Int. 19:692019. View Article : Google Scholar : PubMed/NCBI | |
|
Jahangiri B, Khalaj-Kondori M, Asadollahi E and Sadeghizadeh M: Cancer-associated fibroblasts enhance cell proliferation and metastasis of colorectal cancer SW480 cells by provoking long noncoding RNA UCA1. J Cell Commun Signal. 13:53–64. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hu JJ, Song W, Zhang SD, Shen XH, Qiu XM, Wu HZ, Gong PH, Lu S, Zhao ZJ, He ML and Fan H: HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Sci Rep. 6:235212016. View Article : Google Scholar : PubMed/NCBI | |
|
Lv S, Yuan P, Lu C, Dong J, Li M, Qu F, Zhu Y and Zhang J: QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway. Aging (Albany NY). Feb 11–2021.(Epub ahead of print). doi: 10.18632/aging.202482. View Article : Google Scholar | |
|
Zhou S, Zhu Y, Li Z, Zhu Y, He Z and Zhang C: Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway. J Cell Mol Med. 25:2262–2273. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Goyal B, Yadav SRM, Awasthee N, Gupta S, Kunnumakkara AB and Gupta SC: Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. Biochim Biophys Acta Rev Cancer. 1875:1885022021. View Article : Google Scholar : PubMed/NCBI | |
|
Ghafouri-Fard S, Abak A, Tondro Anamag F, Shoorei H, Majidpoor J and Taheri M: The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process. Biomed Pharmacother. 137:1112792021. View Article : Google Scholar : PubMed/NCBI | |
|
Xin H, Liu N, Xu X, Zhang J, Li Y, Ma Y, Li G and Liang J: Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6. J Cell Biochem. 120:15157–15169. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sun MD, Zheng YQ, Wang LP, Zhao HT and Yang S: Long noncoding RNA UCA1 promotes cell proliferation, migration and invasion of human leukemia cells via sponging miR-126. Eur Rev Med Pharmacol Sci. 22:2233–2245. 2018.PubMed/NCBI | |
|
Sun S, Wu Y, Guo W, Yu F, Kong L, Ren Y, Wang Y, Yao X, Jing C, Zhang C, et al: STAT3/HOTAIR signaling axis regulates HNSCC growth in an EZH2-dependent manner. Clin Cancer Res. 24:2665–2677. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yang R, Wang M, Zhang G, Bao Y, Wu Y, Li X, Yang W and Cui H: E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression. Br J Cancer. 123:1445–1455. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Han H, Wang S, Meng J, Lyu G, Ding G, Hu Y, Wang L, Wu L, Yang W, Lv Y, et al: Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2. Oncogene. 39:6513–6528. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cha TL, Zhou BP, Xia W, Wu Y, Yang CC, Chen CT, Ping B, Otte AP and Hung MC: Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science. 310:306–310. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Chen P, Wan D, Zheng D, Zheng Q, Wu F and Zhi Q: Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother. 83:1220–1226. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yang C, Li X, Wang Y, Zhao L and Chen W: Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene. 496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Gong Y, Jin B, Wu C, Yang J, Wang L, Zhang Z and Mao Z: Long non-coding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells. Oncol Rep. 32:1281–1290. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pan J, Li X, Wu W, Xue M, Hou H, Zhai W and Chen W: Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer Lett. 382:64–76. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li T, Xiao Y and Huang T: HIF1-α-ainduced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway. Oncol Rep. 39:1072–1080. 2018.PubMed/NCBI | |
|
Ma H, Su R, Feng H, Guo Y and Su G: Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway. J Bone Oncol. 16:1002282019. View Article : Google Scholar : PubMed/NCBI | |
|
Wu ZR, Yan L, Liu YT, Cao L, Guo YH, Zhang Y, Yao H, Cai L, Shang HB, Rui WW, et al: Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours. Nat Commun. 9:46242018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu C and Luo J: Long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) enhances tamoxifen resistance in breast cancer cells via inhibiting mTOR signaling pathway. Med Sci Monit. 22:3860–3867. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Popova NV and Jücker M: The Role of mTOR Signaling as a Therapeutic Target in Cancer. Int J Mol Sci. 22:17432021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Li H, Cui Z, Zhou Z, Chen S, Ma J, Hou L, Pan X and Li Q: Long non-coding RNA UCA1 relieves cardiomyocytes H9c2 injury aroused by oxygen-glucose deprivation via declining miR-122. Artif Cells Nanomed Biotechnol. 47:3492–3499. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang QS, Zhou J and Li X: LncRNA UCA1 protects cardiomyocytes against hypoxia/reoxygenation induced apoptosis through inhibiting miR-143/MDM2/p53 axis. Genomics. 112:574–580. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J and Zhang C: Silence of long non-coding RNA UCA1 inhibits hemangioma cells growth, migration and invasion by up-regulation of miR-200c. Life Sci. 226:33–46. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Li X, Wu S, Xue M and Chen W: Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci. 105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
van Andel H, Kocemba KA, Spaargaren M and Pals ST: Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Leukemia. 33:1063–1075. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang B, Fang S, Cheng Y, Zhou C and Deng F: The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway. Aging (Albany NY). 11:8239–8253. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lu HW and Liu XD: UCA1 promotes papillary thyroid carcinoma development by stimulating cell proliferation via Wnt pathway. Eur Rev Med Pharmacol Sci. 22:5576–5582. 2018.PubMed/NCBI | |
|
Liu H, Wang G, Yang L, Qu J, Yang Z and Zhou X: Knockdown of long non-coding RNA UCA1 increases the tamoxifen sensitivity of breast cancer cells through inhibition of Wnt/β-Catenin Pathway. PLoS One. 11:e01684062016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Gao J, Yu Y, Zhao Z and Pan Y: Long non-coding RNA UCA1 targets miR-185-5p and regulates cell mobility by affecting epithelial-mesenchymal transition in melanoma via Wnt/β-catenin signaling pathway. Gene. 676:298–305. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu G, Liu X, Su Y, Kong F, Hong X and Lin Z: Knockdown of urothelial carcinoma-associated 1 suppressed cell growth and migration through regulating miR-301a and CXCR4 in osteosarcoma MHCC97 Cells. Oncol Res. 27:55–64. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen T, Chen Z, Lian X, Wu W, Chu L, Zhang S and Wang L: MUC 15 promotes osteosarcoma cell proliferation, migration and invasion through livin, MMP-2/MMP-9 and Wnt/β-catenin signal pathway. J Cancer. 12:467–473. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Gui X, Li H, Li T, Pu H and Lu D: Long Noncoding RNA CUDR regulates HULC and β-catenin to govern human liver stem cell malignant differentiation. Mol Ther. 23:1843–1853. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lombard DB, Cierpicki T and Grembecka J: Combined MAPK Pathway and HDAC Inhibition Breaks Melanoma. Cancer Discov. 9:469–471. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kong L, Wu Q, Zhao L, Ye J, Li N and Yang H: Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway. Cell Cycle. 18:1212–1228. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li D, Hao S and Zhang J: Long non-coding RNA UCA1 exerts growth modulation by miR-15a in human thyroid cancer TPC-1 cells. Artif Cells Nanomed Biotechnol. 47:1815–1822. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Nixon CC, Mavigner M, Sampey GC, Brooks AD, Spagnuolo RA, Irlbeck DM, Mattingly C, Ho PT, Schoof N, Cammon CG, et al: Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature. 578:160–165. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng Q, Lin Z, Li X, Xin X, Wu M, An J, Gui X, Li T, Pu H, Li H and Lu D: Inflammatory cytokine IL6 cooperates with CUDR to aggravate hepatocyte-like stem cells malignant transformation through NF-κB signaling. Sci Rep. 6:368432016. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Q, Zhao MW and Yang P: LncRNA UCA1 suppresses the inflammation via modulating miR-203-mediated regulation of MEF2C/NF-κB signaling pathway in epilepsy. Neurochem Res. 45:783–795. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Qin L, Jia Z, Xie D and Liu Z: Knockdown of long noncoding RNA urothelial carcinoma-associated 1 inhibits cell viability, migration, and invasion by regulating microRNA-182 in gastric carcinoma. J Cell Biochem. 119:10075–10086. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
de Bock CE, Demeyer S, Degryse S, Verbeke D, Sweron B, Gielen O, Vandepoel R, Vicente C, Vanden Bempt M, Dagklis A, et al: HOXA9 cooperates with activated JAK/STAT signaling to drive leukemia development. Cancer Discov. 8:616–631. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang H, Zhu M, Wang H and Liu H: Suppression of lncRNA MALAT1 reduces pro-inflammatory cytokines production by regulating miR-150-5p/ZBTB4 axis through JAK/STAT signal pathway in systemic juvenile idiopathic arthritis. Cytokine. 138:1553972021. View Article : Google Scholar : PubMed/NCBI | |
|
Yang W, Qian Y, Gao K, Zheng W, Wu G, He Q, Chen Q, Song Y, Wang L, Wang Y, et al: LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes. Carcinogenesis. 42:80–92. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li JL, Liu XL, Guo SF, Yang Y, Zhu YL and Li JZ: Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway. Eur Rev Med Pharmacol Sci. 23:9238–9250. 2019.PubMed/NCBI | |
|
Liu J, Luo C, Zhang C, Cai Q, Lin J, Zhu T and Huang X: Upregulated lncRNA UCA1 inhibits trophoblast cell invasion and proliferation by downregulating JAK2. J Cell Physiol. 235:7410–7419. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Yao G, Li L, Ma Z, Chen J and Chen W: LncRNA-UCA1 inhibits the astrocyte activation in the temporal lobe epilepsy via regulating the JAK/STAT signaling pathway. J Cell Biochem. 121:4261–4270. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Shao T, Song M, Xie Y, Zhou J, Yin J, Ding N, Zou H, Li Y and Zhang J: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer. Mol Cancer. 19:512020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang ZS, Wang J, Zhu BQ and Ge L: Long noncoding RNA UCA1 promotes multiple myeloma cell growth by targeting TGF-beta. Eur Rev Med Pharmacol Sci. 22:1374–1379. 2018.PubMed/NCBI | |
|
Shu T, He L, Wang X, Pang M, Yang B, Feng F, Wu Z, Liu C, Zhang S, Liu B, et al: Long noncoding RNA UCA1 promotes chondrogenic differentiation of human bone marrow mesenchymal stem cells via miRNA-145-5p/SMAD5 and miRNA-124-3p/SMAD4 axis. Biochem Biophys Res Commun. 514:316–322. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Liu H, Zhong Q, Wu J and Tang Z: LncRNA UCA1 is necessary for TGF-β-induced epithelial-mesenchymal transition and stemness via acting as a ceRNA for Slug in glioma cells. FEBS Open Bio. 8:1855–1865. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang M, Zhao Y, Zhang Y, Wang D, Gu S, Feng W, Peng W, Gong A and Xu M: LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. Biochim Biophys Acta Mol Basis Dis. 1864:1770–1782. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tian Y, Zhang X, Hao Y, Fang Z and He Y: Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res. 24:335–341. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Q, Li Y, Lv W, Zhang G, Tian X, Li X, Cheng H and Zhu C: UCA1 promotes cell proliferation and invasion and inhibits apoptosis through regulation of the miR129-SOX4 pathway in renal cell carcinoma. Onco Targets Ther. 11:2475–2487. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Duan Q, Xu M, Wu M, Zhang X, Gan M and Jiang H: Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma. Cancer Med. 9:3115–3129. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li ZG, Xiang WC, Shui SF, Han XW, Guo D and Yan L: 11 Long noncoding RNA UCA1 functions as miR-135a sponge to promote the epithelial to mesenchymal transition in glioma. J Cell Biochem. 121:2447–2457. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun S, Gong C and Yuan K: LncRNA UCA1 promotes cell proliferation, invasion and migration of laryngeal squamous cell carcinoma cells by activating Wnt/β-catenin signaling pathway. Exp Ther Med. 17:1182–1189. 2019.PubMed/NCBI | |
|
Chen X, Wang Z, Tong F, Dong X, Wu G and Zhang R: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer. Mol Ther Nucleic Acids. 19:643–653. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
He C, Lu X, Yang F, Qin L, Guo Z, Sun Y and Wu J: LncRNA UCA1 acts as a sponge of miR-204 to up-regulate CXCR4 expression and promote prostate cancer progression. Biosci Rep. 39:BSR201814652019. View Article : Google Scholar : PubMed/NCBI | |
|
Han R, Chen S, Wang J, Zhao Y and Li G: LncRNA UCA1 affects epithelial-mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells. Cell Cycle. 18:3044–3053. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Gao F, He Q, Li G and Ding G: lncRNA UCA1 functions as a ceRNA to promote prostate cancer progression via sponging miR143. Mol Ther Nucleic Acids. 19:751–758. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Gharib E, Anaraki F, Baghdar K, Ghavidel P, Sadeghi H, Nasrabadi PN, Peyravian N, Aghdaei HA, Zali MR and Mojarad EN: Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis. J Cell Biochem. 120:14780–14790. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Esfandi F, Taheri M, Kholghi Oskooei V and Ghafouri-Fard S: Long noncoding RNAs expression in gastric cancer. J Cell Biochem. 120:13802–13809. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Pan J, Xie X, Li H, Li Z, Ren C and Ming L: Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence. Int J Clin Exp Pathol. 12:2951–2958. 2019.PubMed/NCBI | |
|
Hu ML, Wang XY and Chen WM: TGF-β1 upregulates the expression of lncRNA UCA1 and its downstream HXK2 to promote the growth of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 22:4846–4854. 2018.PubMed/NCBI | |
|
Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J and Liu WC: Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. J Int Med Res. 46:348–356. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Mirzajani S, Ghafouri-Fard S, Habibabadi JM, Arsang-Jang S, Omrani MD, Fesharaki SSH, Sayad A and Taheri M: Expression analysis of lncRNAs in refractory and non-refractory epileptic patients. J Mol Neurosci. 70:689–698. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yu X, Wang R, Han C, Wang Z and Jin X: A panel of urinary long non-coding RNAs differentiate bladder cancer from urocystitis. J Cancer. 11:781–787. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Mahvi DA, Liu R, Grinstaff MW, Colson YL and Raut CP: Local cancer recurrence: The realities, challenges, and opportunities for new therapies. CA Cancer J Clin. 68:488–505. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yao F, Wang Q and Wu Q: The prognostic value and mechanisms of lncRNA UCA1 in human cancer. Cancer Manag Res. 11:7685–7696. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Guo N, Sun Q, Fu D and Zhang Y: Long non-coding RNA UCA1 promoted the growth of adrenocortical cancer cells via modulating the miR-298-CDK6 axis. Gene. 703:26–34. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kang K, Huang YH, Li HP and Guo SM: Expression of UCA1 and MALAT1 long-chain non-coding RNAs in esophageal squamous cell carcinoma tissues is predictive of patient prognosis. Arch Med Sci. 14:752–759. 2018.PubMed/NCBI | |
|
Tang X, Yu L, Bao J, Jiang P and Yan F: Function of long noncoding RNA UCA1 on gastric cancer cells and its clinicopathological significance in plasma. Clin Lab. Nov 1–2019.(Epub ahead of print). doi: 10.7754/Clin.Lab.2019.181233. View Article : Google Scholar | |
|
Yang L, Zhang L, Lu L and Wang Y: lncRNA UCA1 increases proliferation and multidrug resistance of retinoblastoma cells through downregulating miR-513a-5p. DNA Cell Biol. 39:69–77. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Ye C, Liu J and Hu Y: UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Biochem Biophys Res Commun. 501:1034–1040. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Liu Y and Xu X: Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway. J Cell Biochem. 119:6296–6308. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yang YN, Zhang R, Du JW, Yuan HH, Li YJ, Wei XL, Du XX, Jiang SL and Han Y: Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer. Cancer Cell Int. 18:1642018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu HY, Bai WD, Ye XM, Yang AG and Jia LT: Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1. Biochem Biophys Res Commun. 496:1308–1313. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao Y, Jiao C, Lin Y, Chen M, Zhang J, Wang J and Zhang Z: lncRNA UCA1 contributes to imatinib resistance by acting as a ceRNA against miR-16 in chronic myeloid leukemia cells. DNA Cell Biol. 36:18–25. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Yang B and Ma B: The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells. Cancer Chemother Pharmacol. 78:1025–1031. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhen S, Lu J, Chen W, Zhao L and Li X: Synergistic antitumor effect on bladder cancer by rational combination of programmed cell death 1 blockade and CRISPR-Cas9-mediated long non-coding RNA urothelial carcinoma associated 1 knockout. Hum Gene Ther. 29:1352–1363. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravegna G, et al: Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 486:532–536. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liang F, Ren C, Wang J, Wang S, Yang L, Han X, Chen Y, Tong G and Yang G: The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy. Oncogenesis. 8:592019. View Article : Google Scholar : PubMed/NCBI |
